Australian investors witnessed renewed buying interest across healthcare and mining stocks as 4DMedical Limited (ASX: 4DX), FireFly Metals Ltd (ASX: FFM) and Catalyst Metals Limited (ASX: CYL) released significant operational updates that reinforced their respective growth strategies. The announcements, released on 31 July 2026 for 4DMedical and Catalyst Metals and 3 August 2026 for FireFly Metals, highlighted commercial milestones, resource expansion and operational execution, helping drive positive market sentiment. Shares of 4DMedical traded at AU$3.940, up 8.54%, FireFly Metals gained 6.43% to AU$1.862, while Catalyst Metals climbed 6.39% to AU$5.745.4DMedical Expands Commercial FootprintIn its 31 July 2026 quarterly update, 4DMedical showcased continued progress in commercialising its proprietary CT:VQ™ lung imaging platform. As part of its U.S. growth strategy, 4DMedical secured a three-year commercial partnership with SimonMed Imaging, extending CT:VQ™ into one of the country's largest outpatient imaging networks. The rollout is scheduled to commence immediately on commercial terms, without a preliminary trial period, highlighting confidence in the platform's clinical capabilities. Operating revenue for FY26 increased 23% year-on-year to AU$7.2 million, while SaaS deployments expanded to 540 sites globally, excluding SimonMed. The company also finished the year with a strong cash balance of AU$278 million.
The company also strengthened its clinical credentials. A peer-reviewed study published during May 2026 demonstrated that CT:VQ™-guided patient selection improved lung volume reduction surgery response rates from 46% to 76%. During June, 4DMedical launched the CLEAR clinical program to evaluate CT:VQ™ in pulmonary embolism, targeting an estimated US$3 billion U.S. market opportunity. Management believes the program could significantly broaden the commercial potential of its technology.
Beyond organic growth, 4DMedical expanded its artificial intelligence capabilities after completing the acquisition of European imaging AI company contextflow and investing in RevealDx. Strategic collaboration with Azra AI further strengthens patient identification, diagnosis and care coordination across respiratory and oncology workflows, creating a more integrated healthcare ecosystem.FireFly Metals Continues Delivering High-Grade Copper-Gold ResultsFireFly Metals' 3 August 2026 announcement further reinforced confidence in the Green Bay Copper-Gold Project in Newfoundland and Labrador, Canada. The company reported another batch of high-grade drilling results, including standout intersections such as 11.5 metres grading 13.2% copper equivalent, 18.9 metres at 8.2% CuEq, 13.5 metres at 11.1% CuEq, and 65.3 metres at 4.3% CuEq. The latest drilling outcomes are anticipated to contribute to the forthcoming Mineral Resource Estimate update while also supporting the Preliminary Economic Assessment, which remains on track for completion in August.
The underground drilling program continues to focus on converting inferred resources into higher-confidence measured and indicated categories. Six underground drill rigs remain active alongside three regional exploration rigs, while the company continues testing geophysical targets and advancing maiden drilling at Tilt Cove. FireFly also reported approximately AU$196.4 million in cash and liquid investments as at 30 June 2026, providing substantial financial flexibility to continue exploration and project development.
Management highlighted that the latest drilling confirms strong continuity across both the high-grade volcanic massive sulphide zones and the broader footwall mineralisation. The expanding high-grade Core Zone is expected to play a significant role in future mine planning, with resource upgrades anticipated to support future reserve declarations and long-term development plans.Catalyst Metals Builds Momentum at PlutonicCatalyst Metals also impressed investors through its 31 July 2026 quarterly report, highlighting record operational performance across the Plutonic Gold Belt. Gold production reached 31,886 ounces during the June quarter while all-in sustaining costs improved to AU$2,666 per ounce. Annual production totalled 103,761 ounces, remaining within guidance, while quarterly cash increased by AU$54 million to AU$331 million. The company also remains debt free with access to an undrawn AU$100 million debt facility.
Operational development also continued to gather pace. The Trident underground resource increased to 1.1 million ounces, development progressed at the Trident decline, and K2 entered production. Exploration drilling at Cinnamon extended the strike length of the higher-grade underground zone beyond 700 metres, highlighting the potential for an additional future ore source. The company is also evaluating an expansion of processing capacity to between 2.5Mtpa and 3.0Mtpa through refurbishment of a second processing plant.
Catalyst noted that multiple mines are now feeding its central processing facility, allowing the business to transition from investment-heavy development towards higher long-term production. The company continues targeting approximately 200,000 ounces of annual production over a 10-year mine life while maintaining an active exploration program aimed at expanding reserves across the Plutonic Gold Belt.Investors Watching Multiple Growth ThemesAlthough these companies operate in different sectors, each announcement reflected a similar theme—executing strategies designed to create long-term shareholder value. 4DMedical is broadening commercial adoption of advanced lung imaging while strengthening its AI capabilities, FireFly Metals continues demonstrating the scale and quality of its Canadian copper-gold asset through consistent drilling success, and Catalyst Metals is translating operational improvements into stronger production, higher cash generation and continued resource growth. As investors continue seeking companies capable of combining operational delivery with long-term expansion opportunities, these three ASX-listed businesses are likely to remain firmly on the market's watchlist.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Which 3 ASX Stocks Are Leading Today's Market Buzz?
Highlights
Australian investors witnessed renewed buying interest across healthcare and mining stocks as 4DMedical Limited (ASX: 4DX), FireFly Metals Ltd (ASX: FFM) and Catalyst Metals Limited (ASX: CYL) released significant operational updates that reinforced their respective growth strategies. The announcements, released on 31 July 2026 for 4DMedical and Catalyst Metals and 3 August 2026 for FireFly Metals, highlighted commercial milestones, resource expansion and operational execution, helping drive positive market sentiment. Shares of 4DMedical traded at AU$3.940, up 8.54%, FireFly Metals gained 6.43% to AU$1.862, while Catalyst Metals climbed 6.39% to AU$5.745.4DMedical Expands Commercial FootprintIn its 31 July 2026 quarterly update, 4DMedical showcased continued progress in commercialising its proprietary CT:VQ™ lung imaging platform. As part of its U.S. growth strategy, 4DMedical secured a three-year commercial partnership with SimonMed Imaging, extending CT:VQ™ into one of the country's largest outpatient imaging networks. The rollout is scheduled to commence immediately on commercial terms, without a preliminary trial period, highlighting confidence in the platform's clinical capabilities. Operating revenue for FY26 increased 23% year-on-year to AU$7.2 million, while SaaS deployments expanded to 540 sites globally, excluding SimonMed. The company also finished the year with a strong cash balance of AU$278 million.
The company also strengthened its clinical credentials. A peer-reviewed study published during May 2026 demonstrated that CT:VQ™-guided patient selection improved lung volume reduction surgery response rates from 46% to 76%. During June, 4DMedical launched the CLEAR clinical program to evaluate CT:VQ™ in pulmonary embolism, targeting an estimated US$3 billion U.S. market opportunity. Management believes the program could significantly broaden the commercial potential of its technology.
Beyond organic growth, 4DMedical expanded its artificial intelligence capabilities after completing the acquisition of European imaging AI company contextflow and investing in RevealDx. Strategic collaboration with Azra AI further strengthens patient identification, diagnosis and care coordination across respiratory and oncology workflows, creating a more integrated healthcare ecosystem.FireFly Metals Continues Delivering High-Grade Copper-Gold ResultsFireFly Metals' 3 August 2026 announcement further reinforced confidence in the Green Bay Copper-Gold Project in Newfoundland and Labrador, Canada. The company reported another batch of high-grade drilling results, including standout intersections such as 11.5 metres grading 13.2% copper equivalent, 18.9 metres at 8.2% CuEq, 13.5 metres at 11.1% CuEq, and 65.3 metres at 4.3% CuEq. The latest drilling outcomes are anticipated to contribute to the forthcoming Mineral Resource Estimate update while also supporting the Preliminary Economic Assessment, which remains on track for completion in August.
The underground drilling program continues to focus on converting inferred resources into higher-confidence measured and indicated categories. Six underground drill rigs remain active alongside three regional exploration rigs, while the company continues testing geophysical targets and advancing maiden drilling at Tilt Cove. FireFly also reported approximately AU$196.4 million in cash and liquid investments as at 30 June 2026, providing substantial financial flexibility to continue exploration and project development.
Management highlighted that the latest drilling confirms strong continuity across both the high-grade volcanic massive sulphide zones and the broader footwall mineralisation. The expanding high-grade Core Zone is expected to play a significant role in future mine planning, with resource upgrades anticipated to support future reserve declarations and long-term development plans.Catalyst Metals Builds Momentum at PlutonicCatalyst Metals also impressed investors through its 31 July 2026 quarterly report, highlighting record operational performance across the Plutonic Gold Belt. Gold production reached 31,886 ounces during the June quarter while all-in sustaining costs improved to AU$2,666 per ounce. Annual production totalled 103,761 ounces, remaining within guidance, while quarterly cash increased by AU$54 million to AU$331 million. The company also remains debt free with access to an undrawn AU$100 million debt facility.
Operational development also continued to gather pace. The Trident underground resource increased to 1.1 million ounces, development progressed at the Trident decline, and K2 entered production. Exploration drilling at Cinnamon extended the strike length of the higher-grade underground zone beyond 700 metres, highlighting the potential for an additional future ore source. The company is also evaluating an expansion of processing capacity to between 2.5Mtpa and 3.0Mtpa through refurbishment of a second processing plant.
Catalyst noted that multiple mines are now feeding its central processing facility, allowing the business to transition from investment-heavy development towards higher long-term production. The company continues targeting approximately 200,000 ounces of annual production over a 10-year mine life while maintaining an active exploration program aimed at expanding reserves across the Plutonic Gold Belt.Investors Watching Multiple Growth ThemesAlthough these companies operate in different sectors, each announcement reflected a similar theme—executing strategies designed to create long-term shareholder value. 4DMedical is broadening commercial adoption of advanced lung imaging while strengthening its AI capabilities, FireFly Metals continues demonstrating the scale and quality of its Canadian copper-gold asset through consistent drilling success, and Catalyst Metals is translating operational improvements into stronger production, higher cash generation and continued resource growth. As investors continue seeking companies capable of combining operational delivery with long-term expansion opportunities, these three ASX-listed businesses are likely to remain firmly on the market's watchlist.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au